Terms: = Pancreatic cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
96 results:
1. Self-propelled assembly of nanoparticles with self-catalytic regulation for tumour-specific imaging and therapy.
Xia M; Wang Q; Liu Y; Fang C; Zhang B; Yang S; Zhou F; Lin P; Gu M; Huang C; Zhang X; Li F; Liu H; Wang G; Ling D
Nat Commun; 2024 Jan; 15(1):460. PubMed ID: 38212655
[TBL] [Abstract] [Full Text] [Related]
2. Differential spatial distribution of HNF4α isoforms during dysplastic progression of intraductal papillary mucinous neoplasms of the pancreas.
Wong J; Trinh VQ; Jyotsana N; Baig JF; Revetta F; Shi C; Means AL; DelGiorno KE; Tan M
Sci Rep; 2023 Nov; 13(1):20088. PubMed ID: 37974020
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues.
Hořejší K; Jin C; Vaňková Z; Jirásko R; Strouhal O; Melichar B; Teneberg S; Holčapek M
J Biol Chem; 2023 Mar; 299(3):102923. PubMed ID: 36681125
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of BRAF V600E-Mutant Colorectal cancer Treated Effectively by Encorafenib, Binimetinib, and Cetuximab Triple Therapy].
Sakamoto S; Tagai N; Shimada M; Kurebayashi H; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1145-1147. PubMed ID: 36281614
[TBL] [Abstract] [Full Text] [Related]
5. A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma - The Taiwan Cooperative Oncology Group T1217 study.
Bai LY; Li CP; Shan YS; Chuang SC; Chen JS; Chiang NJ; Chen YY; Tsou HH; Chuang MH; Chiu CF; Liu TW; Chen LT
Eur J Cancer; 2022 Sep; 173():123-132. PubMed ID: 35932625
[TBL] [Abstract] [Full Text] [Related]
6. Wilms Tumor 1-Associated Protein Expression Is Linked to a T-Cell-Inflamed Phenotype in pancreatic cancer.
Xu JL
Dig Dis Sci; 2023 Mar; 68(3):831-840. PubMed ID: 35859262
[TBL] [Abstract] [Full Text] [Related]
7. Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in pancreatic cancer.
Schalck A; Sakellariou-Thompson D; Forget MA; Sei E; Hughes TG; Reuben A; Bai S; Hu M; Kumar T; Hurd MW; Katz MHG; Tzeng CD; Pant S; Javle M; Fogelman DR; Maitra A; Haymaker CL; Kim MP; Navin NE; Bernatchez C
Cancer Discov; 2022 Oct; 12(10):2330-2349. PubMed ID: 35849783
[TBL] [Abstract] [Full Text] [Related]
8. Minimally invasive distal pancreatectomy: Chronologic changes in the trends and clinical outcomes through a 15-year, single-center experience with 2212 patients.
Park Y; Hwang DW; Lee JH; Song KB; Jun E; Lee W; Hong S; Kim SC
J Hepatobiliary Pancreat Sci; 2022 May; 29(5):540-551. PubMed ID: 35112510
[TBL] [Abstract] [Full Text] [Related]
9. Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
Krug S; Kegel T; Gress TM; Rinke A; Apostolidis L; Jann H; König A; Hörsch D; Schrader J; Ettrich TJ; Richter M; Steighardt J; Michl P
BMC Cancer; 2021 Nov; 21(1):1206. PubMed ID: 34772353
[TBL] [Abstract] [Full Text] [Related]
10. A Possible Definition of Oligometastasis in pancreatic cancer and Associated Survival Outcomes.
Yamanaka M; Hayashi M; Yamada S; Sonohara F; Takami H; Inokawa Y; Shimizu D; Hattori N; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Anticancer Res; 2021 Aug; 41(8):3933-3940. PubMed ID: 34281856
[TBL] [Abstract] [Full Text] [Related]
11. Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights.
Abdelgawad MA; Musa A; Almalki AH; Alzarea SI; Mostafa EM; Hegazy MM; Mostafa-Hedeab G; Ghoneim MM; Parambi DGT; Bakr RB; Al-Muaikel NS; Alanazi AS; Alharbi M; Ahmad W; Bukhari SNA; Al-Sanea MM
Drug Des Devel Ther; 2021; 15():2325-2337. PubMed ID: 34103896
[TBL] [Abstract] [Full Text] [Related]
12. Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control.
Quixabeira DCA; Zafar S; Santos JM; Cervera-Carrascon V; Havunen R; Kudling TV; Basnet S; Anttila M; Kanerva A; Hemminki A
Front Immunol; 2021; 12():674400. PubMed ID: 34084172
[TBL] [Abstract] [Full Text] [Related]
13. Registrar performance in minimally invasive distal pancreatectomy and effects on postoperative outcomes.
Souche R; Ferrandis C; Gautier A; Guillon F; Bardol T; Fabre JM
Langenbecks Arch Surg; 2021 Nov; 406(7):2357-2365. PubMed ID: 34036406
[TBL] [Abstract] [Full Text] [Related]
14. Streptavidin-functionalized terahertz metamaterials for attomolar exosomal microRNA assay in pancreatic cancer based on duplex-specific nuclease-triggered rolling circle amplification.
Zhan X; Yang S; Huang G; Yang L; Zhang Y; Tian H; Xie F; Lamy de la Chapelle M; Yang X; Fu W
Biosens Bioelectron; 2021 Sep; 188():113314. PubMed ID: 34030095
[TBL] [Abstract] [Full Text] [Related]
15. Antioxidant, pancreatic lipase, and α-amylase inhibitory properties of oat bran hydrolyzed proteins and peptides.
Esfandi R; Seidu I; Willmore W; Tsopmo A
J Food Biochem; 2022 Apr; 46(4):e13762. PubMed ID: 33997997
[TBL] [Abstract] [Full Text] [Related]
16. One-step modification to identify dual-inhibitors targeting both pancreatic triglyceride lipase and Niemann-Pick C1-like 1.
Zhang R; Song Z; Wang X; Xue J; Xing D
Eur J Med Chem; 2021 Apr; 216():113358. PubMed ID: 33725656
[TBL] [Abstract] [Full Text] [Related]
17. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract] [Full Text] [Related]
18. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
[TBL] [Abstract] [Full Text] [Related]
19. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC; Boldrini L; Nardangeli A; D'Aviero A; Buwenge M; Cellini F; Deodato F; Dinapoli N; Frascino V; Macchia G; Morganti AG; Valentini V
J Cancer Res Clin Oncol; 2021 Mar; 147(3):661-667. PubMed ID: 33001271
[TBL] [Abstract] [Full Text] [Related]
20. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract] [Full Text] [Related]
[Next]
